Research

When the U.S. Department of Justice (D.O.J.) and Drug Enforcement Administration (D.E.A.) moved FDA-approved cannabis products and state-licensed medical marijuana...

Tier 1A multistate operator (MSO) Trulieve Cannabis Corp. (CSE: TRUL, NYSE TRLV)’s confirmed listing on the New York Stock Exchange...

Cannabis-themed equities experienced a highly volatile, but news-driven month in April 2026, largely shaped by shifting U.S. federal policy expectations....

The first quarter of 2026 marked another period of contraction and stabilization across regulated cannabis licensing markets in North America....

Cannabis-themed equities experienced a broad-based decline in March 2026, extending the weak start to the year and reinforcing the cannabis...

In February 2026, while many of us waited - quasi-patiently - for the coming of spring, cannabis-related equities featured predictably...

2025 marked another period of significant recalibration and transition for the regulated cannabis industry in the United States. While the...

Once again, cannabis-related equities began 2026 with weakness, extending CRBs’ multi-year underperformance relative to global, broad market indexes. Cannabis-themed benchmarks...

As has been the case for several years, stakeholders in the cannabis space were treated to a combination of legislative...

As we have done for nearly a decade, CRB Monitor provides our clients with the gold standard in cannabis and...